Every material Form 8-K Sylvamo has filed with the SEC since August 01, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Sylvamo reported a third-quarter 2026 net loss of $199 million, or $4.98 per diluted share, driven by a $284 million loss from discontinued operations, primarily a noncash impairment tied to its Europe business. Sales from continuing operations of $645 million and adjusted operating earnings of $53 million were both lower than a year earlier but higher than the second quarter. The company also said it entered a put option agreement with Midas Atlantic Partners for a binding offer to acquire its Europe business, which it says would leave Sylvamo more focused on Latin America and North America.
Net sales from continuing operations were $645 million, versus $662 million in Q3 2025 and $614 million in Q2 2026.
Net loss was $199 million ($4.98 per diluted share), including a $284 million loss from discontinued operations.
Adjusted operating earnings were $53 million ($1.33 per diluted share), versus $72 million ($1.79) a year earlier.
Put option agreement with Midas Atlantic Partners for a binding offer to acquire the Europe business; dividend of $0.45 per share was paid Oct. 16.
Sylvamo entered a put option agreement with Midas Atlantic Partners, backed by The Najafi Companies, for a binding offer to acquire its Europe business. The buyer would take the business with an agreed level of working capital and cash, and Sylvamo would receive 20% of future distributions; no purchase price is stated. The company must complete works council and employee consultations before a final decision, and closing is expected by the end of the first quarter of 2027.
Buyer is Midas Atlantic Partners, in partnership with The Najafi Companies
Sylvamo would receive 20% of future distributions from the business in exchange for the transfer
Final decision follows consultations with works councils and employee representatives
Closing is expected by the end of the first quarter of 2027
Sylvamo reported a second-quarter 2026 net loss of $11 million, compared with net income of $15 million a year earlier, while net sales rose to $806 million from $794 million. Adjusted EBITDA fell to $60 million from $82 million, and free cash flow was negative $23 million, so shareholders face weaker profit in the quarter despite higher sales. Management said it expects a much better earnings performance in the second half of 2026.
Net loss of $11 million, or $0.28 per diluted share, versus net income of $15 million, or $0.37 per share, in Q2 2025
Net sales of $806 million, up from $794 million a year earlier and $755 million in Q1 2026
Adjusted EBITDA of $60 million versus $82 million in Q2 2025; free cash flow was negative $23 million
A $12 million valuation allowance on certain foreign deferred tax assets drove the effective tax rate to 1200%
Sylvamo reported a first-quarter 2026 net loss of $3 million, or $0.08 per diluted share, compared with net income of $27 million a year earlier. Net sales fell to $755 million from $821 million, and adjusted EBITDA dropped to $29 million from $90 million, which the company attributed to a transition year with capacity constraints, lower sales volume and higher costs. The company also declared a $0.45 dividend for the second quarter and did not provide new full-year guidance in the release.
Net loss of $3 million, or $0.08 per diluted share, versus net income of $27 million, or $0.65 per diluted share, in Q1 2025
Net sales of $755 million versus $821 million in Q1 2025 and $890 million in Q4 2025
Adjusted EBITDA of $29 million (4% margin) versus $90 million (11% margin) in Q1 2025; free cash flow was negative $59 million
Board declared a $0.45 dividend for the second quarter, paid April 28
Sylvamo reported fourth-quarter 2025 results, with net income of $33 million and diluted earnings per share of $0.83, down from $81 million and $1.94 in the same quarter of 2024. Net sales were $890 million, down from $970 million, and the company recorded an $11 million goodwill impairment in France, which reduced profit. Management said first-quarter 2026 results will be affected by lower volumes, higher energy costs and the absence of favorable one-time items, and did not give a numeric earnings outlook.
Q4 2025 net sales were $890 million versus $970 million in Q4 2024; diluted EPS was $0.83 versus $1.94.
Q4 2025 adjusted EBITDA was $125 million, a 14% margin, versus $157 million and 16% a year earlier.
Net special items were an after-tax charge of $11 million ($0.27 per diluted share), including the France goodwill impairment.
Full-year 2025 net income was $132 million versus $302 million in 2024, with free cash flow of $44 million.
Sylvamo's board declared a dividend of one preferred share purchase right per common share, payable November 20, 2025, and entered into a Rights Agreement with Computershare Trust Company, N.A. The board adopted the plan after Atlas Holdings directed its two affiliated directors to resign, which terminated a 2023 cooperation agreement; the company says the plan is designed to protect long-term value for all shareowners.
Rights are triggered if a person or group acquires 15% or more of common shares, or 20% for certain passive investors; the trigger was 10% under the 2022 plan.
Atlas Holdings has economic exposure to approximately 21.5% of outstanding common stock, consisting of 16% beneficial ownership and 5.5% through derivatives, per the company.
Each right allows purchase of one one-thousandth of a Series B Preferred Share at $215.00, subject to adjustment; the rights expire November 9, 2026.
Sylvamo reported third-quarter 2025 net income of $57 million ($1.41 per diluted share) on net sales of $846 million, up from $15 million in the second quarter but down from $95 million in the third quarter of 2024. The company expects fourth-quarter 2025 adjusted EBITDA of $115 million to $130 million, below the $151 million it reported for the third quarter, so shareholders face a mixed picture of sequential improvement and a weaker year-over-year and outlook trend.
Q3 2025 net sales of $846 million, up from $794 million in Q2 2025 but down from $965 million in Q3 2024.
Net income of $57 million ($1.41 per diluted share), compared with $95 million ($2.27 per diluted share) in Q3 2024.
Adjusted EBITDA of $151 million (18% margin), versus $82 million in Q2 2025 and $193 million in Q3 2024.
Q4 2025 adjusted EBITDA outlook of $115 million to $130 million.
Sylvamo directors Karl Meyers and Mark Wilde resigned from the board effective November 5, 2025, after Atlas FRM LLC and affiliates delivered resignation notices and waived their right to recommend replacements. The filing says the Atlas cooperation period under the February 14, 2023 agreement will terminate on November 13, 2025, which ends the framework that governed those board seats.
Karl Meyers and Mark Wilde resigned from the Sylvamo board effective November 5, 2025.
Resignations were made under irrevocable letters tied to their initial board appointments under the Cooperation Agreement.
Atlas Group waived its right to recommend substitute directors for either seat.
The Cooperation Period is set to terminate on November 13, 2025.
Sylvamo and International Paper amended two agreements tied to the 2021 spin-off, as International Paper converts its Riverdale mill to containerboard. The supply agreement now runs through April 30, 2026 with wind-down in May and termination on May 30, 2026 unless extended, and the Brazil payment obligation is reduced by $15 million plus a variable amount linked to purchases.
Supply Agreement with IP's Riverdale, Alabama, mill continues through April 30, 2026, then winds down in May; it terminates May 30, 2026 unless extended.
Riverdale paper machine no. 16 is being converted to containerboard by the third quarter of 2026, per IP's August 2025 announcement.
Brazil Payment of $100 million is reduced by $15 million in $3 million annual installments from September 1, 2026 through 2030, plus a variable reduction tied to purchases from October 1, 2025 through May 31, 2026.
Sylvamo director Stan Askren notified the company on August 19, 2025 that he will resign from the Board of Directors, effective September 1, 2025, citing health reasons. The filing states his departure is not due to any disagreement with the company, and the Board thanked him for his service since the 2021 spinoff.
Stan Askren gave notice of his intent to resign on August 19, 2025
Resignation is effective September 1, 2025
Filing cites health reasons and states no disagreement with Sylvamo
Sylvamo reported second quarter 2025 net income of $15 million ($0.37 per diluted share), down from $27 million in the first quarter and $83 million a year earlier, with net sales of $794 million and adjusted EBITDA of $82 million. The company said results were in line with its outlook and guided third quarter adjusted EBITDA to $145 million to $165 million, citing lower planned maintenance outage expenses and improved volumes. For shareholders, the quarter was weaker, but the company expects a stronger second half.
Q2 net sales were $794 million, versus $821 million in Q1 2025 and $933 million in Q2 2024.
Net income was $15 million ($0.37 per diluted share), versus $27 million in Q1 2025 and $83 million in Q2 2024.
Third quarter adjusted EBITDA outlook is $145 million to $165 million, with planned maintenance outage expenses projected to fall by $66 million and no outages planned in the quarter.
$42 million remains on the $150 million share repurchase authorization from September 2023, and the board declared a $0.45 per share third quarter dividend.
Sylvamo reported first-quarter 2025 net income of $27 million, or $0.65 per diluted share, down from $81 million in the fourth quarter of 2024 and $43 million a year earlier, on net sales of $821 million. Free cash flow was negative $25 million. The company guided second-quarter adjusted EBITDA to $75 million to $95 million, compared with $90 million in the first quarter, and said it expects quarterly earnings to improve in the second half, which matters to shareholders because profit and cash generation weakened this quarter.
Q1 2025 net income was $27 million ($0.65 per diluted share), versus $81 million ($1.94) in Q4 2024 and $43 million in Q1 2024.
Net sales were $821 million, versus $970 million in Q4 2024 and $905 million in Q1 2024; adjusted EBITDA was $90 million (11.0% margin).
Free cash flow was $(25) million in Q1 2025, versus $100 million in Q4 2024.
Q2 2025 adjusted EBITDA outlook is $75 million to $95 million, and planned maintenance outage expenses are expected to rise by $36 million.
Sylvamo said Chief Executive Officer Jean-Michel Ribiéras will retire effective December 31, 2025, and that John Sims, the current chief financial officer, will become chief operating officer on May 1, 2025 and CEO on January 1, 2026. Don Devlin, formerly of International Paper, will become chief financial officer on May 1, 2025. The filing describes a planned leadership handover rather than a change in financial results, and it states the retirement is not due to any disagreement with the company or its board.
Ribiéras, who is also chairman, will retire as CEO effective December 31, 2025, and remains a nominee for re-election as director at the May 15, 2025 Annual Meeting
John Sims becomes senior vice president and chief operating officer effective May 1, 2025, and chief executive officer effective January 1, 2026
Don Devlin becomes senior vice president and chief financial officer effective May 1, 2025, with a base salary of $540,000 and a sign-on RSU award valued at $510,000
The compensation terms for Sims as CEO are expected to be set by independent directors before December 31, 2025
Sylvamo reported fourth-quarter and full-year 2024 results. Full-year net income rose to $302 million ($7.18 per diluted share) from $253 million ($5.93) in 2023, while fourth-quarter net income fell to $81 million from $95 million in the third quarter. The company expects first-quarter 2025 adjusted EBITDA of $85 million to $105 million, well below the $157 million reported for the fourth quarter.
Full-year 2024 net sales were $3.8 billion ($3,773 million), up from $3,721 million; adjusted operating EPS was $7.42 vs. $6.51.
Fourth-quarter 2024 net income was $81 million ($1.94 per diluted share), down from $95 million ($2.27) in the third quarter.
First-quarter 2025 outlook: adjusted EBITDA of $85 million to $105 million, with volume projected to decline $20 million to $25 million.
Company paid $154 million of debt in 2024, ending the year with $591 million in net debt, and repurchased about $68 million of stock.
Sylvamo reported third-quarter 2024 results that improved from the second quarter, with net sales of $965 million, net income of $95 million and diluted EPS of $2.27. The company also expects fourth-quarter 2024 adjusted EBITDA of $150 million to $165 million, below the $193 million reported for the third quarter, and says it will return at least 40% of free cash flow to shareowners this year.
Net sales $965 million vs. $933 million in Q2; net income $95 million ($2.27 per diluted share) vs. $83 million ($1.98).
Adjusted EBITDA $193 million (20% margin) vs. $164 million (18% margin) in Q2; free cash flow $119 million vs. $62 million.
Q4 2024 adjusted EBITDA outlook of $150 million to $165 million, including an $8 million operating expense for a planned turbine generator maintenance event at the Eastover, South Carolina, mill.
Q3 included a $7 million after-tax net special items charge ($0.17 per diluted share).
Sylvamo reported second quarter 2024 net income of $83 million, or $1.98 per diluted share, up from $43 million, or $1.02, in the first quarter and from $49 million a year earlier. Adjusted EBITDA rose to $164 million from $118 million, and the company gave a third quarter adjusted EBITDA outlook of $170 million to $185 million, which gives shareholders a view of expected near-term earnings.
Net sales of $933 million, up from $905 million in the first quarter and $919 million in the second quarter of 2023
Free cash flow of $62 million, compared with negative $33 million in the first quarter
Third quarter 2024 adjusted EBITDA outlook of $170 million to $185 million
Net special items were $0 million in the second quarter, compared with a $2 million after-tax charge in the first quarter
On July 31, 2024, Sylvamo refinanced part of its long-term debt, extending several credit facilities and redeeming all $90.1 million of its 7% 2029 Notes. The revolving credit facility was cut from $450 million to $400 million, and the filing says the company reduced borrowing capacity because it no longer needed excess capacity. The filing reports no earnings or operating results, and says other terms are generally consistent with the prior agreements.
Revolving credit facility maturity extended from 2026 to July 31, 2029; capacity reduced from $450 million to $400 million.
New $235 million Term Loan F-2 Facility due July 31, 2031; $140 million borrowed at closing and $95 million available as a delayed draw for 60 days.
All outstanding $90.1 million of 7% 2029 Notes called for full redemption, funded by the new term loan.
Accounts receivable finance facility maturity extended from September 30, 2025 to July 30, 2027; size reduced from $120 million to $110 million.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Sylvamo filing is on SEC EDGAR ↗. 8-K briefs of other companies →